MedImmune

After AstraZeneca, Osbourn Reflects on Roles at CAT & MedImmune

After AstraZeneca, Osbourn Reflects on Roles at CAT & MedImmune

1 month ago   |   Xconomy

MedImmune, AstraZeneca's biologics division, is no more. The pharmaceutical giant announced last year that the name would be retired as part of a research and development...
Read more ...

Chutes & Ladders-Gilead Sciences names Dickinson to CFO role

4 monthes ago   |   Fierce Biotech

Gilead names Dickinson to CFO role; MedImmune CSO Herbst nabs CSO job at Pyxis; Checkmate picks up Wooldridge for CMO.
Read more ...

MedImmune's top cancer researcher jumps ship to small biotech

4 monthes ago   |   Fierce Biotech

MedImmune's vice president of research and head of oncology R&D Ronald Herbst, Ph.D., has followed a series of other AstraZeneca and its biologics arm staffers out the door.
Read more ...

Inovio axes staffers, cancer program to 'sharpen focus,' save cash

7 monthes ago   |   Fierce Biotech

A few months after AstraZeneca's MedImmune unit walked away from some of its R&D work with the biotech, Inovio Pharmaceuticals is cutting 28% of its workforce and swinging the...
Read more ...

MedImmune-lite? Immunocore delves into British Big Pharma's R&D talent pool, again

9 monthes ago   |   Fierce Biotech

Bahija Jallal, David Berman, Koustubh Ranadel, and now Mohammed Dar lines up as the latest AstraZeneca/MedImmune executive to jump ship into U.K. biotech Immunocore.
Read more ...

Sean Bohen to leave AstraZeneca as exodus continues

One year ago   |   Fierce Biotech

The changes and departures keep coming from AstraZeneca. Bloomberg reports that Sean Bohen, CMO and EVP of global medicines development, is out the door, following closely in...
Read more ...

U.K. cancer biotech Immunocore digs into AstraZeneca's biologics arm for new CEO

One year ago   |   Fierce Biotech   |   4 articles

Nearly a year after its former chief Eliot Forster stepped down, Immunocore has a new full-time CEO in Medimmune's president Bahija Jallal.
Read more ...

4D raises $90M to move gene therapies into clinical testing with AstraZeneca and Roche

One year ago   |   Fierce Biotech

4D Molecular Therapeutics raised $90 million in venture capital funding and plans to advance its AAV vector platform and treatments into clinical trials through collaborations...
Read more ...

On Cusp of Gene Therapy Clinical Trial, 4D Molecular Reels in $90M

On Cusp of Gene Therapy Clinical Trial, 4D Molecular Reels in $90M

One year ago   |   Xconomy

4D Molecular Therapeutics is already working with several large pharmaceutical companies to help them develop new gene therapies. Now as its own gene therapy candidate...
Read more ...

Buoyed by long-term organ transplant data, ITBMed bags $67M to advance ex-MedImmune asset

One year ago   |   Fierce Biotech

ITBMed has raised $67 million to advance siplizumab in organ transplant patients. The ex-MedImmune monoclonal antibody impressed in a 10-patient trial, raising hopes that...
Read more ...


Register you to post on BioTech Mag

Free Registration

World Biotechnology Congress 2019

Hilaris Conferences is going to host its premier World Biotechnology Congress 2019 during October 01-02, 2019, Valencia, Spain. Biotechnology 2019 Congress aim to create a... Read more ...

World Biotechnology Congress 2019

Hilaris Conferences is going to host its premier World Biotechnology Congress 2019 during October 01-02, 2019, Valencia, Spain. Biotechnology 2019 Congress aim to create a... Read more ...

2nd International Conference on Tissue Science and Regenerative Medicine

This conference is designed for experts in academia and industries working in the tissue science and regenerative field, this conference will examine cutting-edge research in... Read more ...

Invetx Fetches $15M to Develop Biologic Drugs for Man's Best Friend

Invetx Fetches $15M to Develop Biologic Drugs for Man's Best Friend

Veterinarians have a saying that a cat is not a small dog, says Invetx CEO Juergen Horn. Obviously, a dog of any size isn't the same as a human. But Horn, a veterinarian, says... Read more ...

Lundbeck's Alder Bio Bet Pays Off With FDA Approval of Migraine Drug

Lundbeck's Alder Bio Bet Pays Off With FDA Approval of Migraine Drug

A migraine drug that Lundbeck added to its pipeline via its nearly $2 billion acquisition of Alder BioPharmaceuticals won FDA approval on Friday. The drug, eptinezumab , is... Read more ...

Arima Genomics Completes Series A Financing

SAN DIEGO--Arima Genomics, Inc., a company focused on research tools to accelerate the understanding of genome sequence and structure toward their role in human health and... Read more ...

Viking Therapeutics to Participate in Upcoming Investor Conferences

SAN DIEGO, Feb. 24, 2020 /PRNewswire/ - Viking Therapeutics, Inc. , a clinical-stage biopharmaceutical company focused on the development of novel therapies for metabolic and... Read more ...

Molecular characterization and overexpression analyses of secologanin...

Abstract Camptothecin is a high-value anti-cancerous compound produced in many taxonomically unrelated species. Its biosynthesis involves a complex network of pathways and a... Read more ...

Modulation of the Purine Pathway for Riboflavin Production in Flavinogenic...

Riboflavin is an indispensable nutrient for humans and animals, since it is the precursor of the essential coenzymes FMN and FAD, involved in variety of metabolic reactions... Read more ...

A Critical Review of Genome Editing and Synthetic Biology Applications in...

Being the green gold of the future, microalgae and cyanobacteria have recently attracted considerable interest worldwide, for they can be used to produce different kinds of... Read more ...

Biodegradation of penicillin G from industrial bacteria residue by...

An efficient biodegradation-strengthening approach was developed to improve penicillin G degradation from industrial bacterial residue in an expanded bed adsorption bioreactor... Read more ...

More clues for how the monkeyflower got its spots

The monkeyflower, or Mimulus, though possessing a relatively simple genome is able to produce a stunning array of pigmentation patterns. A team of researchers is one step... Read more ...

A deep dive into cellular aging

Scientists have discovered that mitochondria trigger senescence, the sleep-like state of aged cells, through communication with the cell's nucleus -a nd identified an... Read more ...